PULSE GLUCOCORTICOID THERAPY - THE BIG SHOT REVISTED

Authors
Citation
Jc. Roujeau, PULSE GLUCOCORTICOID THERAPY - THE BIG SHOT REVISTED, Archives of dermatology, 132(12), 1996, pp. 1499-1502
Citations number
37
Categorie Soggetti
Dermatology & Venereal Diseases
Journal title
ISSN journal
0003987X
Volume
132
Issue
12
Year of publication
1996
Pages
1499 - 1502
Database
ISI
SICI code
0003-987X(1996)132:12<1499:PGT-TB>2.0.ZU;2-P
Abstract
The term pulse therapy refers to discontinuous intravenous infusion of very high doses of drugs over a short time. Methylprednisolone (and d examethasone in some countries) is the glucocorticoid most frequently administered this way. Doses of each pulse are not standardized but ar e usually 10 to 20 mg per kilogram of body weight for methylprednisolo ne (250-1000 mg) and 2 to 5 mg per kilogram of body weight (50-200 mg) for dexamethasone. Single doses of 500 mg of methylprednisolone and 1 00 mg of dexamethasone are both considered equivalent to 625 mg of pre dnisone.(1) These very high doses, sometimes termed megadoses, are usu ally given as intravenous infusions over 30 minutes to 1 hour daily or every other day for a total of 1 to 5 administrations. In most indica tions, pulse glucocorticoid therapy is accompanied and/or followed by the continuous administration of low- or intermediate-dose glucocortic oids and/or immunosuppressive agents.